Executive Committee

Kelly Page

Senior Vice President, Global Head of Oncology Strategy and Program Leadership

Ms. Page is Senior Vice President, Global Head of Oncology Strategy and Program Leadership at Arvinas. She has over 25 years of global pharmaceutical industry experience from the research setting through global commercialization, with nearly 20 years of experience in oncology therapeutics.

Ms. Page joins Arvinas after serving as Vice President, Head of Global Commercial, Hematology at AstraZeneca, where she was responsible for ensuring successful commercialization of CALQUENCE®, with functional responsibility for commercial strategy and marketing across the hematology portfolio.

Previously, Ms. Page was at Takeda Oncology where she held roles of increasing responsibility, including global team leadership roles in both the Development and Commercial organizations, with responsibility for global (ex-US) development, registration, and commercialization of ADCETRIS®.

During her time at Takeda, Ms. Page also led Global Project Management for Oncology, served as Head of Global Cell Therapy Commercialization, and Head of Global Oncology Strategy and Planning, with responsibility for the strategic planning, commercial alliance management, forecasting and competitive intelligence groups. She also served as the Head of Takeda Oncology in Germany, where she was accountable for all medical, marketing, sales, and market access activities across all oncology assets.

Prior to Takeda Oncology, Ms. Page spent 15 years at Pfizer in various roles of increasing responsibility in R&D and Commercial.

Ms. Page received her B.S. in Biology and her B.A. in Chemistry from Providence College and obtained her M.B.A. in Business Administration from the University of Rhode Island.